The TNXP chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the TNXP chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The TNXP stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View TNXP Detailed Price Forecast - CNN Money | View TNXP Detailed Summary - Google Finance | ||
View TNXP Detailed Summary - Yahoo! Finance | View TNXP Stock Research & Analysis - Zacks.com |
View TNXP Trends & Analysis - Trade-Ideas | View TNXP Major Holders - Barrons | ||
View TNXP Call Transcripts - NASDAQ | View TNXP Breaking News & Analysis - Seeking Alpha | ||
View TNXP Annual Report - CompanySpotlight.com | View TNXP OTC Short Report - OTCShortReport.com | ||
View TNXP Fundamentals - TradeKing | View TNXP SEC Filings - Bar Chart | ||
View Historical Prices for TNXP - The WSJ | View Performance/Total Return for TNXP - Morningstar | ||
View the Analyst Estimates for TNXP - MarketWatch | View the Earnings History for TNXP - CNBC | ||
View the TNXP Earnings - StockMarketWatch | View TNXP Buy or Sell Recommendations - MacroAxis | ||
View the TNXP Bullish Patterns - American Bulls | View TNXP Short Pain Metrics - ShortPainBot.com |
View TNXP Stock Mentions - StockTwits | View TNXP Stock Mentions - PennyStockTweets | ||
View TNXP Stock Mentions - Twitter | View TNXP Investment Forum News - Investor Hub | ||
View TNXP Stock Mentions - Yahoo! Message Board | View TNXP Stock Mentions - Seeking Alpha |
View Insider Transactions for TNXP - SECform4.com | View Insider Transactions for TNXP - Insider Cow | ||
View TNXP Major Holdings Summary - CNBC | View Insider Disclosure for TNXP - OTC Markets | ||
View Insider Transactions for TNXP - Yahoo! Finance | View Institutional Holdings for TNXP - NASDAQ |
View TNXP Stock Insight & Charts - FinViz.com | View TNXP Investment Charts - StockCharts.com | ||
View TNXP Stock Overview & Charts - BarChart | View TNXP User Generated Charts - Trading View |
3 Biotech Stocks to Dump Before They Go to Zero
Posted on Tuesday April 09, 2024
It is not a bad idea to hunt for biotech stocks to sell. Such stocks have earned a bad reputation among investors, and for good reason. Most biotech companies fail, as their success often hinges on receiving regulatory approval for their products. It is an extremely high-risk sector to invest in. For every promising biotech company that successfully navigates clinical trials and generates multibagger returns, there are 99 others that either fail outright or struggle to deliver any gains at all.
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Posted on Monday April 01, 2024
Positive results from confirmatory Phase 3 RESILIENT study reported in December 2023 position Tonmya™ for fibromyalgia for NDA submission second half of 2024; pre-NDA meeting with FDA scheduled for second quarter 2024 Commercial planning underway, including go-to-market, supply chain and manufacturing strategies, for U.S. launch of Tonmya, a potential new first-line, centrally-acting, non-opioid analgesic for the management of fibromyalgia CHATHAM, N.J., April 01, 2024 (GLOBE NEWSWIRE) -- Tonix
Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct Offering
Posted on Thursday March 28, 2024
CHATHAM, N.J., March 28, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a biopharmaceutical company, today announced it has entered into a securities purchase agreement with existing healthcare focused institutional investors of the Company for the purchase and sale of 14,666,666 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 14,666,666 shares of common stock in a reg
Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi Syndrome
Posted on Monday March 25, 2024
TNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxytocin, a naturally occurring hormone that reduces appetite and eating Prader Willi syndrome is the most common genetic cause of life-threatening childhood obesity CHATHAM, N.J., March 25, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced the U.S. Food and Drug Adm